Cullinan Therapeutics

Recent news

• Rating change
  Morgan Stanley Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/8/17
• Rating change
  H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $35
  Market Newswire · 2026/9/26
• Rating change
  Clear Street Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $47
  Market Newswire · 2026/8/13
• Rating change
  Analysts Offer Insights on Healthcare Companies: BrightSpring Health Services, Inc. (BTSG) and Cullinan Management (CGEM)
  TipRanks · 2026/10/2
• Rating change
  BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $39
  Market Newswire · 2026/7/29
• Rating change
  Clear Street Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $47
  Market Newswire · 2026/8/15
• Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $42
  Market Newswire · 2026/10/7
• Citi Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $33
  Market Newswire · 2026/10/7
• Rating change
  BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $39
  Market Newswire · 2026/7/29
• Rating change
  Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $37
  Market Newswire · 2026/7/29
• Rating change
  A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $33 to $40
  Market Newswire · 2026/9/25
• Rating change
  JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36
  Market Newswire · 2026/9/14
• Rating change
  Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $42
  Market Newswire · 2026/9/16
• BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $40
  Market Newswire · 2026/10/2
• William Blair Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating
  Market Newswire · 2026/10/2
• Rating change
  UBS Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $27
  Market Newswire · 2026/8/17
• Rating change
  Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28
  Market Newswire · 2026/8/14
• H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $35
  Market Newswire · 2026/10/2
• Rating change
  H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/8/17
• Rating change
  A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $30 to $42
  Market Newswire · 2026/9/15

Headlines are aggregated automatically and are not independently verified or edited by our team.